Want to see AU:ATX full AI Analyst Report?
Amplia Therapeutics (ATX) Income Statement
Amplia Therapeutics Income Statement
Last quarter (Q4 2026), Amplia Therapeutics's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Amplia Therapeutics's net income was $-3.53M. See Amplia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 3.78M | $ 4.45M | $ 1.19M | $ 1.98M | |
| $ -92.14K | $ 3.57M | $ 4.01M | $ 1.12M | $ 1.98M | |
| $ 13.09M | $ 10.09M | $ 8.44M | $ 7.40M | $ 5.62M | |
| Depreciation and Amortization | $ 92.14K | $ 85.63K | $ 86.15K | $ 73.37K | $ 3.21K |
| $ -13.09M | $ -6.71M | $ -4.48M | $ -7.26M | $ -3.64M | |
| $ -13.18M | $ -6.52M | $ -4.42M | $ -7.48M | $ -3.64M | |
| $ 694.73K | $ -55.88K | $ -4.52M | $ 84.46K | $ -1.15K | |
| $ -12.49M | $ -6.57M | $ -8.94M | $ -7.39M | $ -3.64M | |
| $ -7.71M | $ -6.57M | $ -4.50M | $ -6.24M | $ -3.64M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.03 | $ -0.03 |
| Diluted EPS | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.03 | $ -0.03 |
| Weighted Average Shares Outstanding | 469.65M | 307.10M | 194.01M | 193.98M | 145.55M |
| Weighted Average Shares Outstanding (Diluted) | 469.65M | 307.21M | 194.01M | 193.98M | 145.55M |
Currency in AUD
